Juan Fraire

Dr. Juan Fraire

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2022 in Molecular Therapy
Verified
Journal Article
Open access
MSMaryam Sharifiaghdam
Maryam Sharifiaghdam
ESElnaz Shaabani
Elnaz Shaabani
RFReza Faridi-Majidi
Reza Faridi-Majidi
SSStefaan C. De Smedt
Stefaan C. De Smedt
Kevin BraeckmansKevin Braeckmans
Kevin Braeckmans
JFJuan Fraire
Juan Fraire
It is well‏ ‏established that macrophages are key regulators of wound healing, displaying impressive plasticity and an evolving phenotype, from an aggressive pro-inflammatory or "M1" phenotype to a pro-healing or "M2" phenotype, depending on the wound healing stage, to ensure proper healing. Because dysregulated macrophage responses have been linked to impaired healing of diabetic wounds, macrophages are being considered as a therapeutic target for improved wound healing. In this review, we first discuss the role of macrophages in a normal skin wound healing process and discuss the aberrations that occur in macrophages under diabetic conditions. Next we provide an overview of recent macrophage-based therapeutic approaches, including delivery of ex-vivo-activated macrophages and delivery of pharmacological strategies aimed at eliminating or re-educating local skin macrophages. In particular, we focus on strategies to silence key regulator genes to repolarize wound macrophages to the M2 phenotype, and we provide a discussion of their potential future clinical translation.

21 October 2021 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
RXRanhua Xiong
Ranhua Xiong
DHDawei Hua
Dawei Hua
JHJelter Van Hoeck
Jelter Van Hoeck
DBDominika Berdecka
Dominika Berdecka
LLLaurens Léger
Laurens Léger
Kevin BraeckmansKevin Braeckmans
Kevin Braeckmans

30 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ETEline Teirlinck
Eline Teirlinck
RXRanhua Xiong
Ranhua Xiong
TBToon Brans
Toon Brans
KFKatrien Forier
Katrien Forier
JFJuan Fraire
Juan Fraire
Kevin BraeckmansKevin Braeckmans
Kevin Braeckmans
Hindered penetration of antibiotics through biofilms is one of the reasons for the alarming increase in bacterial tolerance to antibiotics. Here, we investigate the potential of laser-induced vapour nanobubbles (VNBs) formed around plasmonic nanoparticles to locally disturb biofilm integrity and improve antibiotics diffusion. Our results show that biofilms of both Gram-negative (Burkholderia multivorans, Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria can be loaded with cationic 70-nm gold nanoparticles and that subsequent laser illumination results in VNB formation inside the biofilms. In all types of biofilms tested, VNB formation leads to substantial local biofilm disruption, increasing tobramycin efficacy up to 1-3 orders of magnitude depending on the organism and treatment conditions. Altogether, our results support the potential of laser-induced VNBs as a new approach to disrupt biofilms of a broad range of organisms, resulting in improved antibiotic diffusion and more effective biofilm eradication.

9 March 2023 in Accounts of Chemical Research
Verified
Journal Article
Closed access
RXRanhua Xiong
Ranhua Xiong
FSFélix Sauvage
Félix Sauvage
JFJuan Fraire
Juan Fraire
CHChaobo Huang
Chaobo Huang
SSStefaan De Smedt
Stefaan De Smedt
Kevin BraeckmansKevin Braeckmans
Kevin Braeckmans


17 August 2022 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
ESElnaz Shaabani
Elnaz Shaabani
MSMaryam Sharifiaghdam
Maryam Sharifiaghdam
RFReza Faridi-Majidi
Reza Faridi-Majidi
SSStefaan C. De Smedt
Stefaan C. De Smedt
Kevin BraeckmansKevin Braeckmans
Kevin Braeckmans
JFJuan Fraire
Juan Fraire
Skin injuries and chronic non-healing wounds are one of the major global burdens on the healthcare systems worldwide due to their difficult-to-treat nature, associated co-morbidities, and high health care costs. Angiogenesis has a pivotal role in the wound-healing process, which becomes impaired in many chronic non-healing wounds, leading to several healing disorders and complications. Therefore, induction or promotion of angiogenesis can be considered a promising approach for healing of chronic wounds. Gene therapy is one of the most promising upcoming strategies for the treatment of chronic wounds. It can be classified into three main approaches: gene augmentation, gene silencing, and gene editing. Despite the increasing number of encouraging results obtained using nucleic acids (NAs) as active pharmaceutical ingredients of gene therapy, efficient delivery of NAs to their site of action (cytoplasm or nucleus) remains a key challenge. Selection of the right therapeutic cargo and delivery methods is crucial for a favorable prognosis of the healing process. This article presents an overview of gene therapy and non-viral delivery methods for angiogenesis induction in chronic wounds.